Alcanza Clinical Research Acquires Florida-Based Accel Research Sites Network
Alcanza Clinical Research has announced its acquisition of Accel Research Sites Network for an undisclosed price. Accel Research Sites Network is a multi-specialty network headquartered in Florida, with additional sites in Alabama and Georgia. Accel’s network of 22 sites includes eight clinical research units and 14 embedded sites strategically placed in healthcare settings across the Southeast United States. Alcanza Clinical Research is a network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from underrepresented communities. With locations in Alabama, Florida, Georgia,... Read More »
ArchiMed-Backed NAMSA Acquires CRI
NAMSA, a portfolio company of ArchiMed since September 2020, announced on July 18 its acquisition of Germany-based CRI. The addition of CRI to NAMSA is a significant move for NAMSA in Germany that enhances and expands its CRO offerings throughout Europe and across all markets. The price and terms of the transaction are undisclosed. CRI, The Clinical Research Institute, is a German-based full-service contract research organization (CRO) for phase III and IV clinical trials. NAMSA is a global medical device research company providing a range of services to improve efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. According to data captured in the... Read More »
Atlas Clinical Research Acquires Suburban Research Associates
Atlas Clinical Research announced the addition of Suburban Research Associates to its site network, marking the second clinical research site partnership for the platform. Atlas previously formed a strategic partnership with Rochester Clinical Research in April 2023. Specializing in psychiatric research, Suburban will seek to expand its research impact and leverage Atlas’ site connectivity to better serve trial patients. According to data captured in the LevinPro HC database, this transaction represents the 14th clinical trials acquisition of 2023. Founded in 1999 by Dr. Shivkumar Hatti, Suburban Research Associates is a clinical research site conducting psychiatric research from its... Read More »
Sendero Capital & Angelo Gordon Joint Venture Acquires New Haven MSA MOB
JLL Capital Markets announced on July 12 that it advised on the acquisition of a 53,120-square-foot medical office building (MOB) in Hamden, Connecticut. According to data captured in the LevinPro HC database, this represents the 120th MOB transaction of 2023 JLL represented Sendero Capital and Angelo Gordon, who have formed a programmatic joint venture (also arranged by JLL) for up to $300 million in investments in outpatient healthcare real estate over the next two years, in the acquisition. The purchase of the Hamden MOB is the first acquisition as part of the joint venture, which will focus on value-add and core plus outpatient medical office and surgery center assets throughout the... Read More »
Versiti Acquires Fishers, Indiana-based Quantigen
Versiti has announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. The acquisition expands Versiti’s portfolio across the drug and medical device development pathway and adds complementary expertise supporting clinical trials in infectious disease, women’s health and gastrointestinal and reproductive health. Financial terms of the deal were not disclosed. Based in Fishers, Indiana, Quantigen is a contract research organization (CRO) and a patient diagnostic laboratory whose services are focused on supporting the development of novel diagnostic tests and medical devices. Versiti is a world-class blood health organization with locations across the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
